First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2003-10-16 17:52:11Open Document File Size: 191,73 KBShare Result on FacebookCompanyAmes / Glaxo Wellcome Inc. / /CountryUnited States / /Currencypence / /EventFDA Phase / Product Issues / Product Recall / /FacilityLaboratory Tests / /IndustryTermtopical products / potent topical corticosteroid products / renal clearance accounting / treatment site / mineral oil / /MedicalConditionintracranial hypertension / inflammatory and pruritic manifestations / Allergic contact dermatitis / rosacea and perioral dermatitis / concomitant skin infections / headaches / chronic plaque psoriasis / Skin infection Infected eczema Viral warts Herpes / rash Facial telangiectasia / Atopic Dermatitis / severe psoriasis / telangiectasia / disease / Cushing's syndrome / caused depression / free cortisol test Carcinogenesis / severe eczema / hyperglycemia / telangiectasia Urticaria / folliculitis / eczema / hypopigmentation / acneiform eruptions / secondary infection / bilateral papilledema / numbness / cleft palate / corticosteroid-responsive dermatoses / transient urticaria / miliaria / erythematous rash / disorder / perioral dermatitis / psoriasis / dusky erythema / pustular psoriasis / hypersensitivity / infection / irritation / diaper dermatitis / inflammation / pruritus / human hepatoma cells / /OrganizationDOSAGE AND ADMINISTRATION / /PersonJonathan Wilkin / /Positioninvestigator / physician / General / /Productfluticasone propionate / cosyntropin / drug / CUTIVATE / ACTH / S-013 / /ProvinceOrStateNorth Carolina / /TechnologyPharmacokinetics / /SocialTag |